Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cogent Biosciences, Inc.

Clinical trials sponsored by Cogent Biosciences, Inc., explained in plain language.

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 2

New targeted drug trial launches for Hard-to-Treat cancers

Disease control Not yet recruiting

This early-stage study is testing a new targeted drug called CGT6297 in adults with advanced solid tumors that have a specific genetic change called a PIK3CA mutation. The main goals are to find a safe dose and see if the drug shows early signs of helping to shrink tumors. The st…

Phase: PHASE1 • Sponsor: Cogent Biosciences, Inc. • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC